Stepan Reports First Quarter 2026 Results
First Quarter 2026 Highlights
- Reported net income was a
$41.4 million loss versus$19.7 million of income in the prior year. The current year loss resulted from a previously announced$65.4 million pre-tax restructuring charge. Adjusted net income(1) was$10.3 million , down 47% versus the prior year, largely due to lower Surfactant earnings and higher interest expense. The higher interest expense reflects lower capitalized interest income due to the start-up of thePasadena, TX site. - EBITDA(2) was a negative
$16.5 million versus$58.0 million in the prior year. Current year EBITDA was negatively impacted by the$65.4 million restructuring charge. Adjusted EBITDA(2) was$49.6 million , down 14% year-over-year. - Organic sales volume was flat year-over-year as strong demand within Crop Productivity, Oilfield and Industrial Cleaning was offset by soft European Polymers demand.
- Cash from Operations was
$16.9 million during the quarter. Free cash flow(3) for the quarter was a negative$14.0 million , driven by higher working capital requirements which are typical during the first quarter. - Pre-tax earnings include a
$65.4 million restructuring charge related to the previously announced closure of the Company'sFieldsboro, NJ site and select assets at its Elwood (Millsdale), IL and Stalybridge,UK facilities. The cash impact associated with this restructuring charge was less than$1.0 million during the quarter. - The Company has entered into an agreement to sell a parcel of land near its Millsdale site for
$30 million . This agreement is subject to customary closing conditions and the transaction is expected to close during the second half of the year.
"We are executing Project Catalyst safely and in line with expectations despite early quarter weather-related impacts and the new geopolitical challenges. Global adjusted EBITDA was down
Financial Summary
|
Three Months Ended |
||||||||||||
|
($ in thousands, except per share data) |
2026 |
2025 |
% |
|||||||||
|
|
$ |
604,509 |
$ |
593,255 |
2 |
% |
||||||
|
Operating Income (Loss) |
$ |
(49,622) |
$ |
28,288 |
NM |
|||||||
|
Net Income (Loss) |
$ |
(41,406) |
$ |
19,711 |
NM |
|||||||
|
Earnings per Diluted Share |
$ |
(1.81) |
$ |
0.86 |
NM |
|||||||
|
Adjusted Net Income * |
$ |
10,313 |
$ |
19,310 |
(47) |
% |
||||||
|
Adjusted Earnings per |
$ |
0.45 |
$ |
0.84 |
(46) |
% |
||||||
|
* See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share. |
Percentage Change in
Net sales in the first quarter of 2026 increased 2% year-over-year. This increase reflects higher selling prices and the favorable impact of foreign currency translation. A 3% decline in sales volume partially offset the above. Organic volume was flat and organic net sales were up 4% year-over-year.
|
Three Months Ended |
||||
|
Volume |
(3) |
% |
||
|
Selling Price & Mix |
1 |
% |
||
|
Foreign Translation |
4 |
% |
||
|
Total |
2 |
% |
||
Segment Results
|
Three Months Ended |
||||||||||||
|
($ in thousands) |
2026 |
2025 |
% |
|||||||||
|
|
||||||||||||
|
Surfactants |
$ |
453,687 |
$ |
430,337 |
5 |
% |
||||||
|
Polymers |
$ |
130,029 |
$ |
146,116 |
(11) |
% |
||||||
|
Specialty Products |
$ |
20,793 |
$ |
16,802 |
24 |
% |
||||||
|
Total |
$ |
604,509 |
$ |
593,255 |
2 |
% |
||||||
|
Three Months Ended |
||||||||||||
|
($ in thousands, all amounts pre-tax) |
2026 |
2025 |
% |
|||||||||
|
Operating Income (Loss) |
||||||||||||
|
Surfactants |
$ |
18,548 |
$ |
28,930 |
(36) |
% |
||||||
|
Polymers |
$ |
8,822 |
$ |
8,018 |
10 |
% |
||||||
|
Specialty Products |
$ |
4,715 |
$ |
5,508 |
(14) |
% |
||||||
|
Total Segment |
$ |
32,085 |
$ |
42,456 |
(24) |
% |
||||||
|
Corporate Expenses |
$ |
(81,707) |
$ |
(14,168) |
477 |
% |
||||||
|
Consolidated |
$ |
(49,622) |
$ |
28,288 |
(275) |
% |
||||||
|
Three Months Ended |
||||||||||||
|
($ in millions) |
2026 |
2025 |
% |
|||||||||
|
EBITDA |
$ |
(16.5) |
$ |
58.0 |
(128) |
% |
||||||
|
Adjusted EBITDA |
||||||||||||
|
Surfactants |
$ |
41.1 |
$ |
48.3 |
(15) |
% |
||||||
|
Polymers |
$ |
17.4 |
$ |
16.1 |
8 |
% |
||||||
|
Specialty Products |
$ |
6.2 |
$ |
7.0 |
(11) |
% |
||||||
|
Unallocated Corporate |
$ |
(15.1) |
$ |
(13.9) |
9 |
% |
||||||
|
Consolidated Adjusted EBITDA |
$ |
49.6 |
$ |
57.5 |
(14) |
% |
||||||
Consolidated adjusted EBITDA(2) decreased
- Surfactant net sales were
$453.7 million for the quarter, up 5% versus the prior year. Selling prices were up 2% primarily due to pass through of higher raw material costs, improved product and customer mix, along with pricing actions. Organic sales volume was up 2%, driven by strong demand within the Industrial Cleaning, Oilfield and Crop Productivity end markets. Total sales volume declined 2% due tothe Philippines divestiture in the fourth quarter of 2025. The Company achieved volume growth in all global regions except Asia. Foreign currency translation positively impacted net sales by 5%. Surfactant adjusted EBITDA(2) for the quarter decreased$7.2 million , or 15%, versus the prior year. This decrease was primarily due to higher overhead due to production timing differences inAsia , competitive pressures inMexico , the severe cold snap in theU.S. and higher oleochemicals raw material costs. - Polymer net sales were
$130.0 million for the quarter, an 11% decrease versus the prior year. Selling prices decreased 8%, primarily due to the pass-through of lower raw material costs and competitive pressures. Sales volume decreased 6% in the quarter. North American sales volume was up 5% but this was more than offset by a 19% decline in Europe. Foreign currency translation positively impacted net sales by 3% during the quarter. Polymer adjusted EBITDA(2) increased$1.3 million , or 8%, versus the prior year primarily due to global margin improvement. - Specialty Products net sales were
$20.8 million for the quarter, a 24% increase versus the prior year, primarily due to higher sales volume. Specialty Products adjusted EBITDA(2) decreased$0.8 million , or 11%. The decrease in adjusted EBITDA(2) was primarily due to product mix and lower margins within the medium chain triglycerides product line due to higher raw material costs.
Outlook
"We are executing on Project Catalyst, which is our comprehensive plan designed to further optimize our asset base and create a more productive and agile organization to enable growth. During the first quarter we executed our plans to close our
Notes
(1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.
(2) EBITDA and adjusted EBITDA are non-GAAP measures. See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.
(3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures. Cash generated from operations was
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The Company's common stock is traded on the
More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com
Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about
There are a number of risks, uncertainties and other important factors, many of which are beyond
These forward-looking statements are made only as of the date hereof, and
* * * * *
Tables follow
|
Table I |
||||||||
|
STEPAN COMPANY |
||||||||
|
For the Three Months Ended March 31, 2026 and 2025 |
||||||||
|
(Unaudited – in 000's, except per share data) |
||||||||
|
Three Months Ended |
||||||||
|
2026 |
2025 |
|||||||
|
|
$ |
604,509 |
$ |
593,255 |
||||
|
Cost of Sales |
539,658 |
517,792 |
||||||
|
Gross Profit |
64,851 |
75,463 |
||||||
|
Operating Expenses: |
||||||||
|
Selling |
12,166 |
12,108 |
||||||
|
Administrative |
21,313 |
21,414 |
||||||
|
Research, Development and Technical Services |
14,993 |
14,649 |
||||||
|
Deferred Compensation Expense |
562 |
(996) |
||||||
|
49,034 |
47,175 |
|||||||
|
Business Restructuring |
65,439 |
- |
||||||
|
Operating Income (Loss) |
(49,622) |
28,288 |
||||||
|
Other Income (Expense): |
||||||||
|
Interest, Net |
(5,011) |
(4,126) |
||||||
|
Other, Net |
144 |
502 |
||||||
|
(4,867) |
(3,624) |
|||||||
|
Income (Loss) Before Provision for Income Taxes |
(54,489) |
24,664 |
||||||
|
Provision for Income Taxes |
(13,083) |
4,953 |
||||||
|
Net Income (Loss) |
(41,406) |
19,711 |
||||||
|
Net Income (Loss) Per Common Share |
||||||||
|
Basic |
$ |
(1.81) |
$ |
0.86 |
||||
|
Diluted |
$ |
(1.81) |
$ |
0.86 |
||||
|
Shares Used to Compute Net Income Per |
||||||||
|
Basic |
22,888 |
22,867 |
||||||
|
Diluted |
22,888 |
22,890 |
||||||
|
Table II |
||||||||||||||||
|
Reconciliation of Non-GAAP Net Income (Loss) and Earnings per Diluted Share* |
||||||||||||||||
|
Three Months Ended |
||||||||||||||||
|
($ in thousands, except per share amounts) |
2026 |
EPS |
2025 |
EPS |
||||||||||||
|
Net Income (Loss) Reported |
$ |
(41,406) |
$ |
(1.81) |
$ |
19,711 |
$ |
0.86 |
||||||||
|
Deferred Compensation (Income) Expense |
$ |
477 |
$ |
0.02 |
$ |
(470) |
$ |
(0.02) |
||||||||
|
Environmental Remediation |
$ |
78 |
$ |
0.00 |
$ |
69 |
$ |
0.00 |
||||||||
|
Business Restructuring |
$ |
51,164 |
$ |
2.24 |
$ |
- |
$ |
- |
||||||||
|
Adjusted Net Income |
$ |
10,313 |
$ |
0.45 |
$ |
19,310 |
$ |
0.84 |
||||||||
|
* All amounts in this table are presented after-tax |
The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition. The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators. Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years. These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies. The Company's Annual Report on Form 10-K for the year ended
Summary of First Quarter 2026 Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.
- Deferred Compensation: The first quarter of 2026 reported net income includes
$0.5 million of after-tax expense versus$0.5 million of after-tax income in the prior year. - Environmental Remediation: The first quarter of 2026 reported net income includes
$0.1 million of after-tax expense versus$0.1 million of after-tax expense in the prior year. - Business Restructuring: The first quarter of 2026 reported net income includes
$51.2 million of after-tax expense related to restructuring charges. There were no restructuring charges recognized in the prior year quarter.
|
Table III |
||||||||||||||||
|
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||
|
Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. The cumulative tax effect is typically calculated using the statutory tax rates for the jurisdictions in which the transactions occurred. |
||||||||||||||||
|
Three Months Ended |
||||||||||||||||
|
($ in thousands, except per share amounts) |
2026 |
EPS |
2025 |
EPS |
||||||||||||
|
Pre-Tax Adjustments |
||||||||||||||||
|
Deferred Compensation (Income) Expense |
$ |
628 |
$ |
(626) |
||||||||||||
|
Environmental Remediation Expense |
$ |
102 |
$ |
92 |
||||||||||||
|
Business Restructuring |
$ |
65,439 |
$ |
- |
||||||||||||
|
Total Pre-Tax Adjustments |
$ |
66,169 |
$ |
(534) |
||||||||||||
|
Cumulative Tax Effect on Adjustments |
$ |
(14,450) |
$ |
133 |
||||||||||||
|
After-Tax Adjustments |
$ |
51,719 |
$ |
2.26 |
$ |
(401) |
$ |
(0.02) |
||||||||
|
Table IV |
||||||||||||||||||||
|
Deferred Compensation Plans |
||||||||||||||||||||
|
The full effect of the deferred compensation plans on quarterly pre-tax income was |
||||||||||||||||||||
|
2026 |
2025 |
|||||||||||||||||||
|
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
||||||||||||||||
|
|
$ |
49.98 |
$ |
47.36 |
$ |
47.70 |
$ |
54.58 |
$ |
55.04 |
||||||||||
|
Three Months Ended |
||||||||
|
($ in thousands) |
2026 |
2025 |
||||||
|
Deferred Compensation |
||||||||
|
Operating Income (Expense) |
$ |
(562) |
$ |
996 |
||||
|
Other, net – Mutual Fund Gain (Loss) |
(66) |
(370) |
||||||
|
Total Pre-Tax |
$ |
(628) |
$ |
626 |
||||
|
Total After-Tax |
$ |
(477) |
$ |
470 |
||||
Effects of Foreign Currency Translation
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into
|
($ in millions) |
Three Months Ended |
Change |
Change |
|||||||||||||
|
2026 |
2025 |
|||||||||||||||
|
|
$ |
604.5 |
$ |
593.3 |
$ |
11.2 |
$ |
25.3 |
||||||||
|
Gross Profit |
64.9 |
75.5 |
$ |
(10.6) |
2.5 |
|||||||||||
|
Operating Income |
(49.6) |
28.3 |
$ |
(77.9) |
1.3 |
|||||||||||
|
Pretax Income |
(54.5) |
24.7 |
$ |
(79.2) |
1.4 |
|||||||||||
Corporate Expenses
|
Three Months Ended |
||||||||||||
|
($ in thousands) |
2026 |
2025 |
% |
|||||||||
|
Total Corporate Expenses |
$ |
81,707 |
$ |
14,168 |
477 |
% |
||||||
|
Less: |
||||||||||||
|
Deferred Compensation (Income) Expense |
$ |
562 |
$ |
(996) |
(156) |
% |
||||||
|
Environmental Remediation |
$ |
102 |
$ |
92 |
11 |
% |
||||||
|
Business Restructuring |
$ |
65,439 |
$ |
- |
NM |
|||||||
|
Adjusted Corporate Expenses |
$ |
15,604 |
$ |
15,072 |
4 |
% |
||||||
|
Table V |
||||||||
|
Stepan Company |
||||||||
|
Consolidated Balance Sheets |
||||||||
|
March 31, 2026 and December 31, 2025 |
||||||||
|
March 31, 2026 |
December 31, |
|||||||
|
ASSETS |
||||||||
|
Current Assets |
$ |
906,238 |
$ |
858,959 |
||||
|
Property, |
1,148,164 |
1,219,627 |
||||||
|
Other Assets |
278,935 |
279,116 |
||||||
|
Total Assets |
$ |
2,333,337 |
$ |
2,357,702 |
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
|
Current Liabilities |
$ |
720,453 |
$ |
666,494 |
||||
|
Deferred Income Taxes |
11,052 |
11,450 |
||||||
|
Long-term Debt |
328,415 |
340,975 |
||||||
|
Other Non-current Liabilities |
80,393 |
94,773 |
||||||
|
Total Stepan Company Stockholders' Equity |
1,193,024 |
1,244,010 |
||||||
|
Total Liabilities and Stockholders' Equity |
$ |
2,333,337 |
$ |
2,357,702 |
||||
Selected Balance Sheet Information
The Company's total debt increased by
|
($ in millions) |
|
December 31, |
||||||
|
Net Debt |
||||||||
|
Total Debt |
$ |
651.7 |
$ |
626.7 |
||||
|
Cash |
140.8 |
132.7 |
||||||
|
Net Debt |
$ |
510.9 |
$ |
494.0 |
||||
|
Equity |
1,193.0 |
1,244.0 |
||||||
|
Net Debt + Equity |
$ |
1,703.9 |
$ |
1,738.0 |
||||
|
Net Debt / (Net Debt + Equity) |
30 |
% |
28 |
% |
||||
The major working capital components were:
|
($ in millions) |
|
December 31, |
||||||
|
Net Receivables |
$ |
433.7 |
$ |
388.0 |
||||
|
Inventories |
289.0 |
298.8 |
||||||
|
Accounts Payable |
(285.7) |
(261.7) |
||||||
|
$ |
437.0 |
$ |
425.1 |
|||||
|
Table VI |
||||||||||||||||||||
|
Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA |
||||||||||||||||||||
|
Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance. Management excludes the items listed in the table below because they are non-operational items. Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income. |
||||||||||||||||||||
|
Three Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income (Loss) |
$ |
18.5 |
$ |
8.8 |
$ |
4.7 |
$ |
(81.7) |
$ |
(49.6) |
||||||||||
|
Depreciation and Amortization |
22.6 |
8.6 |
1.5 |
0.4 |
33.0 |
|||||||||||||||
|
Other, Net Income |
- |
- |
- |
0.1 |
0.1 |
|||||||||||||||
|
EBITDA |
$ |
(16.5) |
||||||||||||||||||
|
Deferred Compensation |
- |
- |
- |
0.6 |
0.6 |
|||||||||||||||
|
Environmental Remediation |
- |
- |
- |
0.1 |
0.1 |
|||||||||||||||
|
Business Restructuring |
- |
- |
- |
65.4 |
65.4 |
|||||||||||||||
|
Adjusted EBITDA |
$ |
41.1 |
$ |
17.4 |
$ |
6.2 |
$ |
(15.1) |
$ |
49.6 |
||||||||||
|
Three Months Ended |
||||||||||||||||||||
|
($ in millions) |
Surfactants |
Polymers |
Specialty |
Unallocated |
Consolidated |
|||||||||||||||
|
Operating Income |
$ |
28.9 |
$ |
8.0 |
$ |
5.5 |
$ |
(14.2) |
$ |
28.2 |
||||||||||
|
Depreciation and Amortization |
19.4 |
8.1 |
1.5 |
0.3 |
29.3 |
|||||||||||||||
|
Other, Net Income |
- |
- |
- |
0.5 |
0.5 |
|||||||||||||||
|
EBITDA |
$ |
58.0 |
||||||||||||||||||
|
Deferred Compensation |
- |
- |
- |
(0.6) |
(0.6) |
|||||||||||||||
|
Environmental Remediation |
- |
- |
- |
0.1 |
0.1 |
|||||||||||||||
|
Adjusted EBITDA |
$ |
48.3 |
$ |
16.1 |
$ |
7.0 |
$ |
(13.9) |
$ |
57.5 |
||||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-first-quarter-2026-results-302755237.html
SOURCE
Ruben Velasquez 847-446-7500